ReviewJournal of lipid research2020

Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity.

Stephen L Sturley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.